These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30859184)

  • 1. The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study.
    Huttner A; Wijma RA; Stewardson AJ; Olearo F; Von Dach E; Harbarth S; Brüggemann RJM; Mouton JW; Muller AE
    J Antimicrob Chemother; 2019 Jun; 74(6):1656-1661. PubMed ID: 30859184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers.
    Wijma RA; Huttner A; van Dun S; Kloezen W; Abbott IJ; Muller AE; Koch BCP; Mouton JW
    Int J Antimicrob Agents; 2019 Oct; 54(4):435-441. PubMed ID: 31382030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
    Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
    Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.
    Cho YS; Lim HS; Han S; Yoon SK; Kim H; Cho YL; Nam HS; Bae KS
    Clin Ther; 2019 Jan; 41(1):92-106. PubMed ID: 30559004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis.
    De Velde F; De Winter BCM; Koch BCP; Van Gelder T; Mouton JW;
    J Antimicrob Chemother; 2018 Feb; 73(2):469-476. PubMed ID: 29136160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA;
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrofurantoin plasma- and urine exposure in eight healthy beagle dogs following standard nitrofurantoin dosing regimen.
    Ekstrand C; Michanek P; Salomonsson M; Tegner C; Pelander L
    Res Vet Sci; 2022 Dec; 152():150-155. PubMed ID: 35973234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Monte Carlo simulation to determine optimal dosing regimen for cefetamet sodium for injection.
    Li C; Sun J; Miao J; Qin Y; Wang Y; Yu R; Xiao Y
    J Chemother; 2016 Jun; 28(3):172-9. PubMed ID: 25252727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
    Huttner A; Kowalczyk A; Turjeman A; Babich T; Brossier C; Eliakim-Raz N; Kosiek K; Martinez de Tejada B; Roux X; Shiber S; Theuretzbacher U; von Dach E; Yahav D; Leibovici L; Godycki-Cwirko M; Mouton JW; Harbarth S
    JAMA; 2018 May; 319(17):1781-1789. PubMed ID: 29710295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.
    Wijma RA; Koch BCP; van Gelder T; Mouton JW
    Clin Microbiol Infect; 2018 May; 24(5):528-532. PubMed ID: 28867662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled study.
    Naderer OJ; Dumont E; Zhu J; Kurtinecz M; Jones LS
    J Antimicrob Chemother; 2013 Aug; 68(8):1901-9. PubMed ID: 23557930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative human bioavailability study of macrocrystalline nitrofurantoin and two prolonged-action hydroxymethylnitrofurantoin preparations.
    Guelen PJ; Boerema JB; Vree TB
    Drug Intell Clin Pharm; 1988 Dec; 22(12):959-64. PubMed ID: 3243175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.